Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    16935691 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Withdrawn Pioglitazone Hydrochloride (Actos(Registered Trademark)) to Treat Asthma
Conditions: Asthma;   Airway Inflammation;   Airflow Obstruction;   Airway Hyperactivity
Intervention: Drug: Pioglitazone Hydrochloride

Indicates status has not been verified in more than two years